Who is sponsoring NCT04660318?

NCT04660318 is sponsored by Central Hospital, Nancy, France.

What drugs are being tested in NCT04660318?

Interventions in NCT04660318: Remote photoplethysmography for physiological parameters, standard acquisition system for physiological parameters.

What condition does NCT04660318 study?

NCT04660318 studies Plethysmography, Remote Photoplethysmography Imaging, Physiological Parameters.

Is NCT04660318 still recruiting?

NCT04660318 is currently status unknown. Last updated 30 June 2021.

Last reviewed 2021-06-30 · How we verify

NCT04660318

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessment of Physiological Parameters Measurements (Heart Rate, Respiratory Rate, and Oxygen Saturation) by Standard Acquisition System Compared Remote Photoplethysmography Imaging System l

Status unknown NA Last updated 30 June 2021

What this trial tests

NA trial testing Remote photoplethysmography for physiological parameters in Plethysmography in 1,045 participants. Status unknown.

Timeline

14 December 2020

Primary endpoint
1 May 2022

1 December 2022

Quick facts

Lead sponsor	Central Hospital, Nancy, France
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	diagnostic
Enrollment	1,045
Start date	14 December 2020
Primary completion	1 May 2022
Estimated completion	1 December 2022
Sites	1 location across France

Drugs / interventions tested

Remote photoplethysmography for physiological parameters
standard acquisition system for physiological parameters

Conditions studied

Plethysmography — all drugs for Plethysmography →
Remote Photoplethysmography Imaging — all drugs for Remote Photoplethysmography Imaging →
Physiological Parameters — all drugs for Physiological Parameters →

Sponsor

Central Hospital, Nancy, France

Who can join

18 and older, any sex, with Plethysmography or Remote Photoplethysmography Imaging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Introduced in 1930, photoplethysmography techniques presented the possibility of measuring SpO2 and HR using the absorption of light by the blood to define these signals In recent years, a new approach to photoplethysmography to measure physiological parameters without contact has been developed. This technique, called remote Photoplethysmography Imaging (rPPG), uses the different Red - Green - Blue color spectra at a skin captured by the camera video to determine a plethysmography signal. Although these systems have been technically valid, they have not been clinically evaluated in a health setting. This clinical trial is to assess parameters measurements by rPPG compared standard acquisition system in real conditions

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Remote Photoplethysmography Is an Accurate Method to Remotely Measure Respiratory Rate: A Hospital-Based Trial.
Allado E, Poussel M, Renno J, Moussu A, et al · · 2022 · cited 7× · PMID 35806932 · DOI 10.3390/jcm11133647
Innovative measurement of routine physiological variables (heart rate, respiratory rate and oxygen saturation) using a remote photoplethysmography imaging system: a prospective comparative trial protocol.
Allado E, Poussel M, Moussu A, Saunier V, et al · · 2021 · cited 7× · PMID 34389569 · DOI 10.1136/bmjopen-2020-047896
Accurate and Reliable Assessment of Heart Rate in Real-Life Clinical Settings Using an Imaging Photoplethysmography.
Allado E, Poussel M, Moussu A, Hily O, et al · · 2022 · cited 5× · PMID 36294422 · DOI 10.3390/jcm11206101

Verify or expand the search:

Other trials of Remote photoplethysmography for physiological parameters

Trials testing the same drug.

NCT06231654 — Evaluation of Remote Photoplethysmography to Assist Vital Signs Measure in Pediatrics · NA · recruiting

Other recruiting trials for Plethysmography

Currently open trials in the same condition.

NCT06756633 — Respiratory Functions, Thoracoabdominal Movements and Exercise Capacity in Neuromuscular Diseases · recruiting

Other Central Hospital, Nancy, France trials

Trials by the same sponsor.

NCT06452290 — PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder · NA · not yet recruiting
NCT07518498 — Hypnosis During Mechanical Ventilation Weaning · NA · not yet recruiting
NCT07471334 — Prospective Study of Postictal Psychotic Symptoms Occuring After Video-EEG Monitoring in Focal Epilepsies · NA · not yet recruiting
NCT07414667 — Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification ( · not yet recruiting
NCT07415759 — Imaging of Electrical Properties by MRI: Investigation of Age-Related Changes · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04660318 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Central Hospital, Nancy, France
Last refreshed: 30 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04660318.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing